# Finlombarda Gestioni SGR

> Finlombarda Gestioni SGR is a VC fund in Milan backing Health Care and Biotechnology. See 2 investments, round sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Milan, Italy
- Total investments: 2
- Last investment: Jul 2013
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.finlombardasgr.it

Finlombarda Gestioni SGR is an asset management company constituted on 11 April 2001 and authorized by the Bank of Italy on 27 March 2002 to create, promote and manage Closed-Ended Venture Capital and Private Equity Funds.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Erydel | Based in Urbino, EryDel has developed and patented a technology for drug delivery of pharmacological agents through erythrocytes (red blood cells). This process allow to easily load red blood cells with drugs, proteins, contrasting agents for diagnostic purposes, nanoparticles etc. that can be progressively released into the patient body thusallowing an increased efficacy of the therapy and a reduction of collateral effects. The benefit is extremely significant particularly for chronic pathologies that requires continuous daily treatments for patients which could be substituted by monthly transfusion of blood loaded with specific therapeutic agents. Currently, the solution has been tested by several patients for the treatment of Inflammatory Bowel Diseases (IBDs) such as ulcer colitis and Crohn disease. The company can provide a complete support for the drug delivery process including a specific device for the erythrocytes loading ("Red Cell Loader"), and disposable kits. | $16.5M | Series B | Jul 01, 2013 | http://www.erydel.com |
| Dialectica | Dialectica is a biotechnological company that produces neuronal cellular models. The company was founded in 2004 and is based in Milan, Italy. | $1.8M | Series A | Jan 01, 2006 |  |

2 of 2 investments shown.

## Co-investors
- [Genextra](https://shizune.co/investors/profile/genextra) — VC Fund, 1 deal together
- [Innogest Capital](https://shizune.co/investors/profile/innogest-sgr) — VC Fund, 1 deal together
- [Principia SGR](https://shizune.co/investors/profile/quantica-sgr) — VC Fund, 1 deal together
- [State Street Global Advisors](https://shizune.co/investors/profile/state-street-global-advisors) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [CDP Venture Capital](https://shizune.co/investors/profile/cdp-venture-capital) — VC Fund
- [Club degli Investitori](https://shizune.co/investors/profile/club-degli-investitori) — VC Fund
- [Primo Capital](https://shizune.co/investors/profile/barcamper-ventures) — VC Fund

## Featured in investor lists
- [Health Care VC Funds in Italy](https://shizune.co/investors/health-care-vc-funds-italy)
- [Biotechnology VC Funds in Italy](https://shizune.co/investors/biotechnology-vc-funds-italy)

## FAQ

### What does Finlombarda Gestioni SGR invest in?

Finlombarda Gestioni SGR invests primarily in Health Care and Biotechnology startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Finlombarda Gestioni SGR last invest?

The most recent investment recorded for Finlombarda Gestioni SGR closed in Jul 2013. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co